BTCC / BTCC Square / foolstock /
Bitcoin Price Prediction: Will Today’s FOMC Rate Cut to 4.25% Ignite the Next Crypto Supercycle?

Bitcoin Price Prediction: Will Today’s FOMC Rate Cut to 4.25% Ignite the Next Crypto Supercycle?

Author:
foolstock
Published:
2025-09-17 01:45:00
12
1

Fed drops hammer with surprise 4.25% rate cut—crypto markets holding their breath.

The Liquidity Floodgates Open

Cheaper money traditionally flows into risk assets faster than Wall Street bankers can say 'asymmetric upside.' Bitcoin's correlation with liquidity injections isn't speculation—it's economic physics.

Historical Precedents Don't Lie

Previous rate cut cycles saw BTC rip 200%+ within months. This time? Institutional adoption's added rocket fuel to the equation.

Technical Setup Screens 'Buy Signal'

On-chain metrics flashing green while traditional finance scrambles to reprice risk. Smart money's already positioning.

Because nothing makes digital gold shine brighter than fiat currency getting deliberately devalued—but hey, 'this time is different,' right?

A history of fundamental and dividend growth

Medtronic's generous dividend started off modestly in the long-ago days of 1977, at well under $0.01 per share. Management started adding to the payout the following year and never stopped; ultimately that tiny amount ballooned to the current level of $0.71 per share.

Healthcare professional inspecting charts.

Image source: Getty Images.

While all four of the company's current four business segments have shown sales growth lately -- ranging from under 1% to nearly 6% in the most recently reported quarter -- investors have been concerned that Medtronic isn't developing new products quickly enough. Yet the development process for devices, like that for medicines, can be halting at times.

Still, Medtronic is a crucial operator in the medical supply chain, and its fundamentals usually head north. In its most recent fiscal year, revenue ticked up by almost 4% over the previous frame to $33.5 billion, while headline net income leaped 27% skyward to almost $4.7 billion. That shook out to a meaty bottom-line margin of 14%.

An income investor's dream

So even when Medtronic isn't wowing the medical world with an ultra-innovative new device, its wares enjoy sufficient demand to keep the growth train running. Meanwhile, that dividend is quite generous for these times -- the current yield is over 3% -- and almost certain to keep rising. This stock, then, offers a fine combination of decent fundamental growth and an attractive, constant shareholder payout.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users